Sensei Biotherapeutics Stock Analysis

Sensei Stock Analysis Notes

About 34.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.3. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sensei Biotherapeutics recorded a loss per share of 1.19. The entity had not issued any dividends in recent years. Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland. Sensei Biotherapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. To find out more about Sensei Biotherapeutics contact John MBA at 240 243 8000 or learn more at https://www.senseibio.com.

Sensei Biotherapeutics Investment Alerts

Sensei Biotherapeutics Upcoming and Recent Events

Sensei Largest EPS Surprises

View All Earnings Estimates

Sensei Stock Institutional Investors

Note, although Sensei Biotherapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sensei Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.97 M.

Sensei Profitablity

Management Efficiency

Sensei Biotherapeutics has return on total asset (ROA) of (0.2703) % which means that it has lost $0.2703 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4517) %, meaning that it created substantial loss on money invested by shareholders. Sensei Biotherapeutics' management efficiency ratios could be used to measure how well Sensei Biotherapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of December 1, 2024, Return On Tangible Assets is expected to decline to -0.48. The current year's Return On Capital Employed is expected to grow to -0.51. At present, Sensei Biotherapeutics' Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting.

Technical Drivers

As of the 1st of December, Sensei Biotherapeutics has the Risk Adjusted Performance of 0.0384, semi deviation of 7.8, and Coefficient Of Variation of 2634.67. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sensei Biotherapeutics, as well as the relationship between them. Please validate Sensei Biotherapeutics variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Sensei Biotherapeutics is priced more or less accurately, providing market reflects its prevalent price of 0.54 per share. As Sensei Biotherapeutics is a penny stock we also advise to double-check its total risk alpha numbers.

Sensei Biotherapeutics Price Movement Analysis

Sensei Biotherapeutics Insider Trading Activities

Sensei Biotherapeutics Outstanding Bonds

Sensei Biotherapeutics Predictive Daily Indicators

Sensei Biotherapeutics Forecast Models

Sensei Biotherapeutics' time-series forecasting models are one of many Sensei Biotherapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sensei Biotherapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sensei Biotherapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sensei shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sensei Biotherapeutics. By using and applying Sensei Stock analysis, traders can create a robust methodology for identifying Sensei entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Sensei analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Sensei analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Sensei Biotherapeutics stock analysis indicators help investors evaluate how Sensei Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Sensei Biotherapeutics shares will generate the highest return on investment. By understating and applying Sensei Biotherapeutics stock analysis, traders can identify Sensei Biotherapeutics position entry and exit signals to maximize returns.

When running Sensei Biotherapeutics' price analysis, check to measure Sensei Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensei Biotherapeutics is operating at the current time. Most of Sensei Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Sensei Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensei Biotherapeutics' price. Additionally, you may evaluate how the addition of Sensei Biotherapeutics to your portfolios can decrease your overall portfolio volatility.